SYK — Neutral (ASignal Rank 3/4)
ASignal's 10+ AI agent pipeline rates SYK as Neutral with 76% confidence in the Healthcare sector.
AI Analysis Summary
Strong bearish signal due to extreme leverage, overvaluation, and negative technical momentum despite short-term oversold conditions.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 35/100
- Bill Ackman (Activist Investing): Grade B — 56/100
- Ray Dalio (Macro/Risk Parity): Grade D — 35/100
Consensus: Bearish
Price Intelligence
- Current price: $329.01
- Price target: $274.73 (-16.5%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: fair
- Competitive moat: none
Peer Group Analysis
SYK is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.